115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39020)
  2. GSK Faculty (22460)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16081)
  6. Survivorship Research (15757)
  7. Center for Hematologic Malignancies (13259)
  8. Hematologic Malignancies, Division of (13084)
  9. Sloan Kettering Institute Postdocs (12930)
  10. Department of Pathology and Laboratory Medicine (12600)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39020)
  2. GSK Faculty (22460)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16081)
  6. Survivorship Research (15757)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1223)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma
    Journal Article

    Wolchok, J. D.; Chiarion-Sileni, V.; Rutkowski, P.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Queirolo, P.; Dummer, R.; Butler, M. O.; Hill, A. G.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Increased synthetic cytotoxicity of combinatorial chemoradiation therapy in homologous recombination deficient tumors
    Journal Article

    Ma, J.; Shah, R.; Bell, A. C.; McDermott, N.; Pei, X.; Selenica, P.; Haseltine, J.; Delsite, R.; Khan, A. J.; Lok, B. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Building diversity and cultural competence to remove medical imaging barriers
    Review

    Romain, M. C.
    Radiologic Technology (2025)

    Fulltext@MSK | Save
  • Obesity and GLP-1s
    Editorial

    Birn, C. S.
    Gastroenterology Nursing (2025)

    Fulltext@MSK | Save
  • Reply to: Disparities in allograft access in the era of post-transplant cyclophosphamide-based mismatched unrelated donor transplantation
    Correspondence

    Shaffer, B. C.; Gooptu, M.; DeFor, T.; Spellman, S. R.; Stefanski, H. E.; Shaw, B. E.; Auletta, J. J.; Devine, S. M.; Jimenez, A. M.; Al Malki, M. M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Large language model GPT-4 compared to endocrinologist responses on initial choice of glucose-lowering medication under conditions of clinical uncertainty
    Journal Article

    Flory, J. H.; Ancker, J. S.; Kim, S. Y. H.; Kuperman, G.; Petrov, A.; Vickers, A.
    Diabetes Care (2025)

    Fulltext@MSK | Save
  • Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor–positive human epidermal growth factor receptor 2–negative breast cancer: Primary results from TROPION-Breast01
    Journal Article

    Bardia, A.; Jhaveri, K.; Im, S. A.; Pernas, S.; De Laurentiis, M.; Wang, S.; Martínez Jañez, N.; Borges, G.; Cescon, D. W.; Hattori, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Menin inhibition with revumenib for KMT2A -rearranged relapsed or refractory acute leukemia (AUGMENT-101)
    Journal Article

    Issa, G. C.; Aldoss, I.; Thirman, M. J.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • How racialized approaches to opioid use disorder and opioid misuse management hamper pharmacoequity for cancer pain
    Editorial

    Jones, K. E.; Liou, K. T.; Ashare, R. L.; Worster, B.; Yeager, K. A.; Merlin, J.; Meghani, S. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT exon 11 + 17/18 mutations
    Meeting Abstract

    Heinrich, M. C.; Blay, J. V.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Gelderblom, H.; Zalcberg, J. R.; Reichmann, W.; Sprott, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save